Grace Therapeutics Operating Expenses Growth & History (GRCE)
Grace Therapeutics's operating expenses was $11.1M for fiscal 2026.
View full Grace Therapeutics company overviewGrace Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $11.1M | −$5.6M | −33.59% |
| 2025 | 2025-03-31 | $16.7M | $5.3M | +46.73% |
| 2024 | 2024-03-31 | $11.4M | −$6.9M | −37.70% |
| 2023 | 2023-03-31 | $18.2M | $2.7M | +17.05% |
| 2022 | 2022-03-31 | $15.6M | −$950,000 | −5.74% |
| 2021 | 2021-03-31 | $16.5M | — | — |
Grace Therapeutics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $2.4M | −$706,000 | −22.85% |
| Q4 2026 | 2026-03-31 | $3.0M | −$173,000 | −5.44% |
| Q3 2026 | 2025-12-31 | $2.4M | — | — |
| Q2 2026 | 2025-09-30 | $2.5M | — | — |
| Q1 2026 | 2025-06-30 | $3.1M | — | — |
| Q4 2025 | 2025-03-31 | $3.2M | — | — |
| Q3 2022 | 2021-12-31 | $4.5M | $2.5M | +122.70% |
| Q3 2021 | 2020-12-31 | $2.0M | — | — |
Grace Therapeutics operating expenses trends
Over the last five fiscal years, Grace Therapeutics's operating expenses decreased from $16.5M to $11.1M, a change of −$5.5M. The latest reported quarter, Q1 2027, shows $2.4M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Grace Therapeutics source filings ↗